Table 3 Serum (S) (ng/ml) and tumor homogenate (T) (ng/g) steroid hormone concentrations in control and indole-3-carbinol (I3C) groups after 3 weeks of treatment

0.12 ± 0.03 ^a,1

0.24 ± 0.05 ^a,1

13.71 ± 2.42 ^a,2

27.09 ± 3.09 ^b,2

11.98 ± 0.82 ^a,1

12.62 ± 1.01 ^a,1

7.44 ± 0.60 ^a,2

13.89 ± 0.99 ^b,1

5.96 ± 0.77 ^a,1

6.10 ± 1.28 ^a,1

5.16 ± 0.99 ^a,1

20.46 ± 5.17 ^b,2

1.20 ± 0.09 ^a,1

1.76 ± 0.25 ^b,1

12.16 ± 3.07 ^a,2

4.02 ± 1.21 ^b,1

2.96 ± 0.16 ^a,1

3.06 ± 0.37 ^a,2

2.32 ± 0.11 ^a,1

2.86 ± 0.63 ^a,2

0.69 ± 0.07 ^a,1

1.15 ± 0.10 ^b,1

5.37 ± 1.04 ^a,2

7.75 ± 1.98 ^a,2